934 related articles for article (PubMed ID: 18699797)
21. The effect of mu and kappa opioid receptor agonists on cAMP level in hippocampus of kainic acid-treated rats.
Dziedzicka-Wasylewska M; Przewłocki R
Pol J Pharmacol; 1995; 47(2):121-6. PubMed ID: 8688884
[TBL] [Abstract][Full Text] [Related]
22. Effect of opioid receptor ligands injected into the rostral lateral hypothalamus on c-fos and feeding behavior.
Li D; Olszewski PK; Shi Q; Grace MK; Billington CJ; Kotz CM; Levine AS
Brain Res; 2006 Jun; 1096(1):120-4. PubMed ID: 16716266
[TBL] [Abstract][Full Text] [Related]
23. Attenuation of the gerbil writhing response by mu-, kappa- and delta-opioids, and NK-1, -2 and -3 receptor antagonists.
Gallantine EL; Meert TF
Pharmacol Biochem Behav; 2004 Sep; 79(1):125-35. PubMed ID: 15388292
[TBL] [Abstract][Full Text] [Related]
24. Estrogen reduces efficacy of mu- but Not kappa-opioid agonist inhibition in response to uterine cervical distension.
Sandner-Kiesling A; Eisenach JC
Anesthesiology; 2002 Feb; 96(2):375-9. PubMed ID: 11818771
[TBL] [Abstract][Full Text] [Related]
25. Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox.
Peckham EM; Barkley LM; Divin MF; Cicero TJ; Traynor JR
Brain Res; 2005 Oct; 1058(1-2):137-47. PubMed ID: 16139823
[TBL] [Abstract][Full Text] [Related]
26. SA14867, a newly synthesized kappa-opioid receptor agonist with antinociceptive and antipruritic effects.
Tsukahara-Ohsumi Y; Tsuji F; Niwa M; Nakamura M; Mizutani K; Inagaki N; Sasano M; Aono H
Eur J Pharmacol; 2010 Nov; 647(1-3):62-7. PubMed ID: 20813108
[TBL] [Abstract][Full Text] [Related]
27. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids.
Barrett AC; Cook CD; Terner JM; Craft RM; Picker MJ
Psychopharmacology (Berl); 2001 Nov; 158(2):154-64. PubMed ID: 11702089
[TBL] [Abstract][Full Text] [Related]
28. Morphine, oxycodone, methadone and its enantiomers in different models of nociception in the rat.
Lemberg K; Kontinen VK; Viljakka K; Kylänlahti I; Yli-Kauhaluoma J; Kalso E
Anesth Analg; 2006 Jun; 102(6):1768-74. PubMed ID: 16717324
[TBL] [Abstract][Full Text] [Related]
29. Effects of kappa-opioid receptor agonists on responses to colorectal distension in rats with and without acute colonic inflammation.
Burton MB; Gebhart GF
J Pharmacol Exp Ther; 1998 May; 285(2):707-15. PubMed ID: 9580617
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the antinociceptive response to morphine and morphine-like compounds in male and female Sprague-Dawley rats.
Peckham EM; Traynor JR
J Pharmacol Exp Ther; 2006 Mar; 316(3):1195-201. PubMed ID: 16291875
[TBL] [Abstract][Full Text] [Related]
31. A comparison of the antinociceptive and adverse effects of the mu-opioid agonist morphine and the delta-opioid agonist SNC80.
Gallantine EL; Meert TF
Basic Clin Pharmacol Toxicol; 2005 Jul; 97(1):39-51. PubMed ID: 15943758
[TBL] [Abstract][Full Text] [Related]
32. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
[TBL] [Abstract][Full Text] [Related]
33. Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
Tham SM; Angus JA; Tudor EM; Wright CE
Br J Pharmacol; 2005 Mar; 144(6):875-84. PubMed ID: 15778704
[TBL] [Abstract][Full Text] [Related]
34. Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.
Obara I; Makuch W; Spetea M; Schütz J; Schmidhammer H; Przewlocki R; Przewlocka B
Eur J Pharmacol; 2007 Mar; 558(1-3):60-7. PubMed ID: 17204264
[TBL] [Abstract][Full Text] [Related]
35. Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.
Mathews JL; Peng X; Xiong W; Zhang A; Negus SS; Neumeyer JL; Bidlack JM
J Pharmacol Exp Ther; 2005 Nov; 315(2):821-7. PubMed ID: 16076937
[TBL] [Abstract][Full Text] [Related]
36. Morphine withdrawal modifies antinociceptive effects of acute morphine in rats.
Dong Z; Mao R; Han H; Cao J; Xu L
Biochem Biophys Res Commun; 2006 Jul; 346(2):578-82. PubMed ID: 16762316
[TBL] [Abstract][Full Text] [Related]
37. Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys.
Pitts RC; Allen RM; Walker EA; Dykstra LA
J Pharmacol Exp Ther; 1998 Jun; 285(3):1197-206. PubMed ID: 9618423
[TBL] [Abstract][Full Text] [Related]
38. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
[TBL] [Abstract][Full Text] [Related]
39. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
Baker AK; Hoffmann VL; Meert TF
Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic evaluation of pressor and visceromotor reflex responses to bladder distension.
Su X; Riedel ES; Leon LA; Laping NJ
Neurourol Urodyn; 2008; 27(3):249-53. PubMed ID: 17598175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]